Crane Rosemary A 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Crane Rosemary A
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-13+5,000→ 5,000 totalExercise: $33.14Exp: 2034-06-12→ Common Stock (5,000 underlying) - Award
Restricted Stock Units
2024-06-13+3,350→ 3,350 total→ Common Stock (3,350 underlying)
Footnotes (3)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.